Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
In times of financial crisis, knowing how to get emergency funds fast is crucial. Explore various options to secure the funds you need.
17,560 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
When the stock market just made a bold move, savvy investors sit up and take notice. This piece breaks down Buffett's...
A yen-hedged approach to Japan equities outperformed the unhedged EWJ by roughly six percentage points in the first h...
Billionaire investor Warren Buffett expanded his charity reach with a multi-billion-dollar donation this week, illust...
In a bold move amid 13F season, investor Gavin Baker places a major levered bet on Nvidia through call options, signa...
Kanen Wealth Management added a substantial stake in Compass, prompting questions about compass stock after kanen. Th...
A leading hedge fund poured nearly $40 million into GRAIL last quarter, only to see the stock tumble. This article un...
When a big holder trims a stake in a robotics and AI ETF, it sparks questions about conviction and risk. This guide b...
A looming recession can rattle nerves, but retirees don’t have to panic. Here are three clear moves to shore up cash,...
Kick off your weekend with focused, actionable investing reads. This guide helps you pick credible sources, turn insi...
Global markets tumble as President Trump’s policy shifts on Iran fuel uncertainty. Investors scramble to gauge exit p...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...